During ageing, the secretory patterns of the hormones produced by the hypothalamic–
pituitary axis change, as does the sensitivity of the axis to negative feedback by end …

ABSTRACT Background The Global Consensus Position Statement on the Use of
Testosterone Therapy for Women (Global Position Statement) recommended testosterone …

Abstract The International Menopause Society (IMS) has produced these new 2016
recommendations on women's midlife health and menopause hormone therapy (MHT) to …

This Statement is being simultaneously published in the journals Climacteric, Maturitas,
Journal of Sexual Medicine, and Journal of Clinical Endocrinology and Metabolism on …

Background The benefits and risks of testosterone treatment for women with diminished
sexual wellbeing remain controversial. We did a systematic review and meta-analysis to …

Sexual function worsens with advancing menopause status. The most frequently reported
symptoms include low sexual desire (40–55%), poor lubrication (25–30%) and dyspareunia …

Objective: To update practice guidelines for the therapeutic use of androgens in women.
Participants: A Task Force appointed by the Endocrine Society, American Congress of …

Abstract The International Society for the Study of Women's Sexual Health process of care
(POC) for management of hypoactive sexual desire disorder (HSDD) algorithm was …

Menopause is the cessation of ovarian function, with loss of reproductive hormone
production and irreversible loss of fertility. It is a natural part of reproductive aging. The …

Sexual well-being frequently declines following the menopause transition and can be
associated with significant personal and relationship distress. This distress is the hallmark of …